Siren LLC’s Entera Bio ENTX Stock Holding History

Siren LLC’s Portfolio ENTX Stock Details ENTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$17.5M	Buy	6,000,000 +5,263,543	+715%	+$14.1M	0.41%	53
2026 Q2	$1.3M	Buy	+736,457	New	+$921K	0.03%	110

Other funds holding ENTX

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $106B AUM 21.33% 1-Year Est. Return

Signature Estate & Investment Advisors Los Angeles, California $5.67B AUM 20.02% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return

Siren LLC's ENTX Position: Q3 2026 in Review

Siren LLC increased its Entera Bio (ENTX) stake by 715% in Q3 2026, buying an estimated $14.1M and bringing the position to 6,000,000 shares worth $17.5M. The position accounts for 0.41% of the portfolio, ranked #53.

Siren LLC first reported a position in ENTX in Q2 2026 and has held it in 2 quarters since. 12 funds tracked by Wall St. Rank hold ENTX as of Q3 2026.

Siren LLC held 6,000,000 shares of Entera Bio worth $17.5M as of Q3 2026.
Siren LLC bought 5,263,543 Entera Bio shares in Q3 2026, an estimated $14.1M.
Entera Bio made up 0.41% of Siren LLC's portfolio in Q3 2026, its #53 holding.
Siren LLC first reported a position in Entera Bio in Q2 2026 and has held it in 2 quarters since.
12 funds tracked by Wall St. Rank held Entera Bio as of Q3 2026.

Based on Siren LLC's 13F filing for Q3 2026, filed 12 Nov 2026.